Combined endoscopic stent-in-stent placement for malignant biliary and duodenal obstruction by using a new duodenal metal stent (with videos)

Gastrointest Endosc. 2009 Oct;70(4):772-7. doi: 10.1016/j.gie.2009.04.013.

Abstract

Background: Self-expandable metal stents (SEMSs) are an effective palliative treatment for malignant biliary or duodenal strictures, but endoscopic stenting for combined malignant biliary and duodenal obstruction remains technically difficult.

Objective: To evaluate the feasibility and clinical success rate of endoscopic double stent-in-stent placement by using a new duodenal metallic stent for the management of malignant biliary and duodenal obstructions.

Design: Prospective, observational clinical feasibility study.

Setting: Tertiary referral center.

Main outcome measurement: Technical and clinical success, complications, midterm outcome.

Patients and methods: Eight patients with inoperable malignant biliary and duodenal strictures were enrolled. Endoscopic placement of a biliary SEMS was performed through the mesh of the duodenal stent.

Results: The duodenal strictures were in the first part of the duodenum in 3 patients (type 1) and in the second part in 5 patients (type 2). Duodenal stents were successfully deployed in all patients. Endoscopic placement of a biliary SEMS through the mesh of the duodenal stent was successful in 7 (87.5%) of 8 patients. In 2 of 3 patients with type 2 duodenal strictures with failed bile duct cannulation, biliary stenting was successful by using the rendezvous procedure. Early complications occurred in 1 patient. The overall median survival after combined stenting was 91 days (range 36-314 days).

Limitations: Small number of patients and no comparison with other enteral stents.

Conclusions: Biliary stenting through the new duodenal metallic stent is technically feasible and has a high success rate. Combined endoscopic biliary and duodenal stent-in-stent placement is a promising solution for the palliation of malignant biliary and duodenal obstruction.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cholestasis / etiology
  • Cholestasis / therapy*
  • Constriction, Pathologic
  • Digestive System Neoplasms / complications*
  • Duodenal Obstruction / etiology
  • Duodenal Obstruction / therapy*
  • Endoscopy, Gastrointestinal
  • Feasibility Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Palliative Care
  • Prospective Studies
  • Prosthesis Implantation
  • Stents*
  • Treatment Outcome